Global Cord Blood (NYSE:CO) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO) in a research report released on Monday. The brokerage issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

NYSE CO opened at $1.25 on Monday. The stock has a market capitalization of $151.94 million, a PE ratio of 1.95 and a beta of 0.16. The stock has a 50-day simple moving average of $1.39 and a 200 day simple moving average of $1.36. Global Cord Blood has a twelve month low of $2.03 and a twelve month high of $5.50.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.